- Stocks
- Healthcare
- NASDAQ: PGNY

Price (delayed)

$33.45

Market cap

$3.12B

P/E Ratio

101.36

Dividend/share

N/A

EPS

$0.33

Enterprise value

$3.01B

Progyny is a leading fertility benefits management company in the US. The company is redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously

The revenue has surged by 57% year-on-year and by 12% since the previous quarter

PGNY's equity is up by 50% year-on-year and by 9% since the previous quarter

The EPS has dropped by 55% year-on-year and by 28% since the previous quarter

The net income has plunged by 54% YoY and by 28% from the previous quarter

What are the main financial stats of PGNY

Market
Valuations
Earnings

Shares outstanding

93.38M

Market cap

$3.12B

Enterprise value

$3.01B

Price to earnings (P/E)

101.36

Price to book (P/B)

8.24

Price to sales (P/S)

3.92

EV/EBIT

127.39

EV/EBITDA

119.31

EV/Sales

3.82

Revenue

$786.91M

EBIT

$23.63M

EBITDA

$25.23M

Free cash flow

$77.15M

Per share
Balance sheet
Liquidity

EPS

$0.33

Free cash flow per share

$0.84

Book value per share

$4.06

Revenue per share

$8.54

TBVPS

$5.76

Total assets

$542.99M

Total liabilities

$166.02M

Debt

$6.48M

Equity

$376.97M

Working capital

$274.32M

Debt to equity

0.02

Current ratio

2.72

Quick ratio

2.69

Net debt/EBITDA

-4.5

Margins
Efficiency
Dividend

EBITDA margin

3.2%

Gross margin

21.3%

Net margin

3.9%

Operating margin

3%

Return on assets

6.3%

Return on equity

9.2%

Return on invested capital

9.1%

Return on capital employed

6.2%

Return on sales

3%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Progyny stock price performed over time

Intraday

-0.15%

1 week

-1.21%

1 month

4.43%

1 year

-33.14%

YTD

7.38%

QTD

7.38%

How have Progyny's revenue and profit performed over time

Revenue

$786.91M

Gross profit

$167.33M

Operating income

$23.34M

Net income

$30.36M

Gross margin

21.3%

Net margin

3.9%

The company's net margin has shrunk by 70% YoY and by 35% QoQ

The revenue has surged by 57% year-on-year and by 12% since the previous quarter

The net income has plunged by 54% YoY and by 28% from the previous quarter

PGNY's operating margin has dropped by 54% year-on-year but it is up by 7% since the previous quarter

What is Progyny's growth rate over time

What is Progyny stock price valuation

P/E

101.36

P/B

8.24

P/S

3.92

EV/EBIT

127.39

EV/EBITDA

119.31

EV/Sales

3.82

The EPS has dropped by 55% year-on-year and by 28% since the previous quarter

The stock's price to earnings (P/E) is 29% more than its last 4 quarters average of 78.7

PGNY's equity is up by 50% year-on-year and by 9% since the previous quarter

PGNY's price to book (P/B) is 23% lower than its last 4 quarters average of 10.7

The revenue has surged by 57% year-on-year and by 12% since the previous quarter

PGNY's price to sales (P/S) is 27% lower than its last 4 quarters average of 5.4

How efficient is Progyny business performance

The company's return on equity has shrunk by 70% YoY and by 35% QoQ

Progyny's return on assets has shrunk by 69% YoY and by 34% QoQ

PGNY's return on invested capital has dropped by 56% year-on-year but it is up by 10% since the previous quarter

The return on sales has dropped by 53% year-on-year but it has grown by 7% since the previous quarter

What is PGNY's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for PGNY.

How did Progyny financials performed over time

PGNY's total liabilities has surged by 56% year-on-year

PGNY's total assets has soared by 52% YoY and by 6% from the previous quarter

The company's debt is 98% lower than its equity

PGNY's equity is up by 50% year-on-year and by 9% since the previous quarter

PGNY's debt to equity is down by 33% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.